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Abstract The most commonly used methods for assess-
ing the selenium (Se) status in humans involve analysis of
Se concentration, selenoprotein activity, and concentration
in the blood and its compartments. Recently, it has been
suggested that the expression of selenoprotein mRNA in
circulating blood leukocytes could differently reﬂect Se
status, due to prioritization of speciﬁc selenoprotein syn-
thesis in response to dietary Se supply. Whereas the Se
levels required for optimization of selenoprotein P level
and plasma glutathione peroxidise activity are well known,
estimation of Se level that is required for maximal mRNA
expression of selenoprotein in humans is the subject of
current investigations. Studies on rats suggest that whole
blood selenoprotein mRNA level can be used as the rele-
vant molecular biomarker for assessing Se status, and
suboptimal Se intake may be sufﬁcient to achieve effective
expression. Human studies, however, did not conﬁrm this
hypothesis. According to studies on rodents and humans
discussed in this review, it appears that suboptimal Se
intake may be sufﬁcient to satisfy molecular requirements
of Se and it is lower than current recommended dietary
intake in humans. The use of selenoprotein transcripts as a
molecular biomarker of Se status requires further studies
on a large group of healthy individuals with different
baseline Se, including data regarding genetic polymor-
phism of selenoproteins and data regarding potential
modiﬁers of Se metabolism.
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Introduction
Discovered by Berzelius in 1817, selenium (Se) belongs to
the 16 group (formerly group 6A) in the periodic table,
together with oxygen, sulfur, tellurium, and polonium
(Nogueira and Rocha 2011). Initially, Se was considered
only as a toxic element, but for several decades it has been
known as an essential trace element associated with sig-
niﬁcant health beneﬁts in humans and mammals (Schwarz
and Foltz 1958). The basic role of Se activity is its presence
in catalytic sites of various selenoproteins. In eukaryotic
cells, Se can be incorporated into 25 human and 24 rodent
selenoproteins during translation, as selenocysteine (Sec),
21st aminoacid, which is unique for essential trace ele-
ments incorporation (Hesketh 2008). Selenoproteins may
perform various functions in humans, including antioxidant
action (e.g., glutathione peroxidases), transport and storage
of Se (selenoprotein P), redox signaling (thioredoxin
reductases), thyroid hormone metabolism (iodothyronine
deiodinases), protein folding (e.g., selenoprotein 15 kDa),
and others (Table 1).
The role of Se and selenoproteins in human health and
diseases has been intensively studied with special attention
on the determination of relevant biomarkers of Se status.
The measured Se status depends mainly on dietary intakes.
In the diet, Se is largely found in animal foods, and to a
lesser extent also in plants, which indicates large individual
differences in Se intake, associated with dietary menu
composition, but also with the origin of food, which can be
grown (plants) or bred (animals) on soils with different Se
content (Gromadzinska et al. 2008). In humans, dietary Se
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Well documented Se deﬁciency health effects—Keshan
and Kashin-Beck (KBD) diseases, associated with muscle
disorders, were found in a broad zone running from
northeast to southwest China, from the border of Hei-
longjiang to the Yunnan province, where concentration of
Se in the soil was very low (Oldﬁeld 1999). In European
countries, dietary Se intake is lower than that observed in
USA, mainly due to low Se soils. Recommended dietary
intake (RDI) value of Se for adults in USA and Europe is
55 lg/day. Tolerable upper intake level determined by the
US Food and Nutrition Board (NAS 2000) is 400 lg/day,
while that determined by the Scientiﬁc Committee on Food
in Europe is 300 lg/day (EFSA 2008). Average intake of
Se by European population ranges from 27 to 70 lg per
day (EFSA 2008), which is insufﬁcient to meet the daily
requirement. Clinical signs of marginal Se deﬁciency in
Europe have not been observed or documented yet. How-
ever, it should be noted that several groups of healthy
individuals may be specially prone to Se deﬁciency, which
includes breast-fed neonates, pregnant women, and elderly
people (Bellinger et al. 2009).
The relationship between Se level and health effects is
represented by a U-shaped curve that suggests health
pathologies associated with Se deﬁciency as well as its
excess (Ip 1998; Jablonska et al. 2008). The altered Se
status resulting from insufﬁcient Se intake is very often
associated with different diseases, including immune dis-
eases, cardiological diseases, and cancer. On the other
hand, recent studies have indicated that long-term high
Table 1 Human selenoproteins
Function Abbreviations Selenoprotein Cellular; tissue localization
Antioxidant
enzymes
GPx1
a Cytosolic glutathione peroxidase
(GPx)
Cytosol, mitochondria; widely expressed
GPx2
a Gastrointestinal GPx Cytosol, ER; gastrointestinal tissue, liver
GPx3 Plasma GPx Secreted; plasma, extracellular ﬂuid, liver, kidney, heart, lung,
thyroid, gastrointestinal tissue, breast
GPx4
a Phospholipid hydroperoxide GPx Cytosol, mitochondria, nucleus; widely expressed, testes
GPx6 Olfactory GPx Unknown; embryo and oilfactory epithelium
SelK Selenoprotein K ER, membrane protein
SelR Selenoprotein R; methionine
sulfoxide reductase B1
Cytosol, nucleus; widely expressed
SelW Selenoprotein W Cytosol; widely expressed, brain, colon, heart, skeletal muscle,
prostate
Transport and
storage of Se
SepP1
a Selenoprotein P Secreted, cytosol; plasma, widely expressed, brain, liver, testes
Redox signaling TrxR1
a Thioredoxin reductase, type I Cytosol, nucleus; widely distributed
TrxR2 Thioredoxin reductase, type II Mitochondria; widely distributed
TrxR3 Thioredoxin reductase, type III Cytosol, ER, nucleus; testis-speciﬁc
Thyroid hormone
metabolism
DIO1 Iodothyronine deiodinase, type I Membrane protein; kidney, liver, thyroid, brown adipose tissue
DIO2 Iodothyronine deiodinase, type II ER, membrane protein; thyroid, central nervous system, brown
adipose tissue, skeletal muscle
DIO3 Iodothyronine deiodinase, type III Membrane protein; placenta, central nervous system, fetus
Protein folding Sep15
a Selenoprotein 15 kDa ER lumen
SelN Selenoprotein N ER membrane; widely expressed
SelM Selenoprotein M ER lumen
SelS
a,b Selenoprotein S ER, membrane protein; widely expressed
Sec synthesis SPS2 Selenophosphate synthetase Cytosol
Unknown SelH Selenoprotein H Nucleus; widely expressed
SelI Selenoprotein I Transmembrane
SelO Selenoprotein O Unknown
SelT Selenoprotein T ER membrane
SelV Selenoprotein V Testes
Adapted from Papp et al. (2007), Shchedrina et al. (2010), Fairweather-Tait et al. (2010)
a Genetic polymorphism associated with cancer
b Inﬂammatory disease
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123dietary Se supply seems to be related to the risk of type 2
diabetes, amyotrophic lateral sclerosis, and some types of
cancer (Bellinger et al. 2009; Nogueira and Rocha 2011).
Although Se levels in blood and blood compartments are
easily accessible markers of human Se nutritional status, Se
level itself does not reﬂect its functional signiﬁcance.
Plasma or serum Se, very often used in various Se inves-
tigations, reﬂects rather short-term Se status, while platelet,
leukocyte, and erythrocyte Se reﬂects its longer-term sta-
tus. Two best known selenoprotein biomarkers that have
been widely used in discriminating of Se status are as
follows: plasma selenoprotein P (SePP1) level and plasma
glutathione peroxidase (GPx3) activity. In healthy humans,
plasma Se is incorporated as Sec in two selenoproteins:
SePP1 (40–70%), GPx3 (20–40%), while 6–10% of Se is
bound to albumin in the form of selenomethionine, through
the replacement of methionine. Free Se accounts for less
than 1% of total plasma Se (Vincent and Forceville 2008).
These biomarkers generally reﬂect the major sources of
human body Se, because GPx3 and SePP1 are the unique
secreted selenoproteins. GPx3 is mainly synthesized in
kidney, where it is produced by the cells of proximal
tubular ephitelium and by parietal cells of Bowman’s
capsule and then it is released into the plasma (Grom-
adzinska et al. 2008; Reeves and Hoffmann 2009). Mam-
malian SePP1 that contains multiple Sec residues (10 Sec
residues in humans and rodents) is synthesized in liver and
then secreted into the blood and transported to other tis-
sues. Therefore, SePP1 serves as Se transporter and Se
body distribution controller. Recently, speciﬁc apolipo-
protein E receptor-2 (ApoER2) for SePP1 uptake in brain
and testis and ApoER2 homolog—megalin—for SePP1
uptake in kidney proximal tubule epithelial cells were
found, suggesting receptor-mediated uptake of Se in these
organs (Burk and Hill 2009).
There is a growing interest in the use of transcripts level
as a molecular biomarker with special regard to whole
blood. Since early 1990s, research on this new molecular
biomarker of Se status has been extended to Se studies in
rodents, showing prioritization of preservation and degra-
dation of speciﬁc selenoprotein mRNA under Se deﬁciency
and under conditions of adequate and enhanced supply
(Bermano et al. 1995). The observed hierarchy of the
expression of selenoprotein mRNA in response to dietary
Se supply has indicated the order of selenoproteins, some
of them dramatically affected under Se deﬁciency or its
excess, and others only marginally. Selenoprotein tran-
scripts analysis in the blood gives an opportunity to obtain
genomic ﬁngerprints, in response to Se status, but also
reﬂect an impact of genetic polymorphism of selenopro-
teins. In a few recent human studies, selenoprotein gene
expression level in circulating human blood leukocytes was
used as a longer term Se status indicator. Some other
studies have been focused on the role of Se incorporation
during selenoprotein synthesis under different Se dietary
status in humans (Pagmantidis et al. 2008; Ravn-Haren
et al. 2008a, b; Reszka et al. 2009; Sunde et al. 2008).
Levels of Se for optimization of SePP1 concentration
and GPx3 activity in plasma have been determined in
people living in Se-adequate areas. However, these bio-
markers may be unsuitable under conditions of high Se
status, because of plateau levels obtained at such concen-
trations. On the other hand, Se levels in blood of individ-
uals living in low Se areas with low Se intake may be
insufﬁcient to ensure maximal activity and/or concentra-
tion of selenoproteins GPx3 and SePP1 (Thomson 2004).
Therefore, determination of Se intake and Se status in
humans with variable Se supply seems to be important in
assessing the most sensitive Se status biomarkers. In this
review, we present recent ﬁndings regarding molecular Se
biomarkers, based on rodent and human studies.
Traditional biomarkers of Se status
Se status measured by serum/plasma Se, plasma SePP1
concentration and plasma GPx3 activity may differently
respond to Se supplementation, which can give information
about low, adequate, and high Se dietary intake. Since
several years, it has been generally accepted that seleno-
protein level and/or activity may be more useful in deter-
mining Se status than Se itself. Two human selenoproteins,
GPx3, and SePP1 are believed to be good nutritional Se
biomarkers in humans. Studies on Se-deﬁcient populations
showed that full expression of SePP1 required larger intake
of Se than did GPx3 activity (Xia et al. 2005, 2010).
Therefore, setting RDI values for Se intake was based on
their assessment of the amount of Se required to achieve
optimal activity or two-thirds optimal activity of GPx3 in
plasma to meet the requirements of people living in low,
adequate, and high Se areas (Rayman 2004).
Different chemical forms of dietary Se from animal
foods and plants, such as selenite, selenocysteine, and
selenomethionine, are involved in metabolic pathways to
form selenide. Selenide is then transformed into Sec for
selenoprotein biosynthesis or may be methylated to the
main metabolite—selenosugar and then excreted with urine
(Rayman 2004). Selenomethionine is a major form of
organic selenium in plant foods, similarly like selenium-
enriched yeast in Se supplements. Because of different
metabolism of Se compounds in organism, absorption of Se
from different organic and inorganic Se food sources, and
Se supplements, their incorporation in selenoprotein and
urinary Se excretion may vary in humans. Studies on North
Americans (Burk et al. 2006) and Se-deﬁcient Chinese
subjects (Xia et al. 2005) clearly indicate that Se in the
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123form of selenomethionine is more easily absorbed than
selenite. Absorption of Se from yeast was greater than this
inorganic form but less than selenomethionine. Interest-
ingly, plasma Se seemed to reﬂect selenomethionine con-
tent of yeast but not the other yeast Se forms, indicating its
effective bioavailability (Burk et al. 2006).
In several populations in suboptimal Se areas in Europe,
China, New Zealand, concentration of SePP1 could not
reach the plateau because of low Se daily intake, sug-
gesting that Se nutritional requirements had not been
achieved (Xia et al. 2005). In Se-deﬁcient Chinese subjects,
different plateaus reached by plasma GPx3 activity and
plasma SePP1 level indicates that the latter is a better
indicator of Se status in humans, because a larger intake of
Se has been required for optimized SePP1 concentration
than did GPx3 activity (Xia et al. 2010). In addition to
GPx3 activity, plasma SePP1 level may be a suitable Se
status and Se intake biomarker in individuals from low Se
populations with additional supply of Se. In populations
living in high Se areas, e.g., Australia (Queensland), USA,
and Canada (central states and provinces) (Oldﬁeld 1999),
where GPx3 activity and SePP1 level in plasma can be
optimized by dietary Se supply, plasma Se seems to reﬂect
Se status and Se intake (Burk et al. 2006).
Molecular biomarkers of Se status
The unique conserved stem-loop Sec insertion sequence
(SECIS) in the 30-untranslated region of mammalian sele-
noprotein mRNA is essential for the recognition of UGA as
a codon for Sec. Sec may be synthesised from different Se
dietary sources: selenomethionine, selenocysteine or sele-
nite, Se compounds which are further metabolized to sel-
enide and then in the presence of selenophosphate
synthetase 2 to selenophosphate This process requires
speciﬁc Sec tRNA[Ser]Sec, several translation factors like
SBP2, EFSeC, and others that serve to distinguish between
UGA codons designated for Sec from those terminating
translation. Sec synthesis occurs directly on its Sec
tRNA[Ser]Sec, initially carrying a serine residue, which
serves as an acceptor for selenophosphate. Maturation of
Sec tRNA[Ser]Sec requires methylation, and two isoforms
of methylated and unmethylated Sec tRNA[Ser]Sec are
observed. Se supplementation is known to modulate the
relative ratio between these two isoforms and promote the
methylation of Sec tRNA[Ser]Sec. (Hatﬁeld and Glady-
shev 2002; Hesketh and Villette 2002; Jameson and
Diamond 2004; Schomburg and Schweizer 2009; Small-
Howard and Berry 2005).
It has been observed that the alterations in selenoprotein
activity and concentration during Se depletion and reple-
tion are accompanied by changes in the mRNA level.
Under severe Se deﬁciency, this microelement is accu-
mulated mainly in the brain and endocrine tissues, where
elevated expression and activity of phospholipid glutathi-
one peroxidase (GPx4) and thyroxine deiodinase (DIO)
were observed, indicating the biological importance of
these selenoproteins (Schomburg and Schweizer 2009).
According to rodent studies, the main selenoproteins that
are resistant to dietary Se changes are GPx4 and DIO;
thioredoxine reductases (TrxR) and SePP1 are moderately
sensitive, while GPx1, SelW, SelH are very sensitive to
low Se supply (Reeves and Hoffmann 2009; Sunde 2010).
Several in vitro and in vivo studies have shown that, under
Se deﬁciency, the degradation of selenoprotein mRNA
occurs through NMD (nonsense codon-mediated mRNA
decay) (Moriarty et al. 1998; Weiss and Sunde 1998). Due
to speciﬁc nucleotide sequences and preferential binding of
SBP2 translation factor, 14 of 25 human selenoprotein
mRNAs may be sensitive to NMD-based degradation under
low Se supply (Squires et al. 2007). However, a study on
rodents, suggesting regulation of selenoprotein expression,
irrespective of this hypothetical preference, indicates that
also other mechanisms concerning differences in the
expression efﬁciency of some selenoproteins under Se
deﬁciency must exist (Sunde et al. 2009). In addition,
methylated Sec tRNA[Ser]Sec supports the biosynthesis of
selenoproteins GPx1, GPx3, SelR, SelT, sensitive to low Se
supply, while other selenoproteins, like TrxR1 and GPx4,
moderately sensitive and resistant to low Se supply, require
unmethylated isoform (Schomburg and Schweizer 2009).
Selenoprotein transcripts in rodents
An attempt to answer the question whether selenoprotein
gene expression may be used as a biomarker of Se status
was presented for the ﬁrst time by Roger A. Sunde’s team.
Sepp1 mRNA shows the highest expression in rat testes and
liver, while Gpx3 mRNA expression is highest in rat kid-
ney (Evenson et al. 2004), which is in agreement with
observed selenoprotein activity and protein expression in
these organs. Therefore, these molecular biomarkers may
be also useful for the determination of Se status as well as
for establishing physiological requirements of Se for ade-
quate selenoprotein gene expression. These authors found
also that, in rodents, Gpx1, Selh, and Selw mRNA levels
were highly regulated by Se status (Sunde 2010). Analysis
of hierarchical regulation of different selenoprotein
mRNAs by Se status indicates that Gpx1 transcripts level is
the best and adequate molecular biomarker in rats, because
dietary Se deﬁciency similarly decreased Gpx1 mRNA in
blood and liver. By way of comparison, decrease in Se
supply in diet did not affect Gpx4 mRNA in liver and
blood. Gpx1 mRNA expression in rat liver was the highest,
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123while in blood, expression of this selenoprotein was at 4th
place in tissue rank, comparable with the expression in
heart and kidney. Interestingly, other investigated seleno-
protein transcripts also presented distinct expression pat-
tern across the tissues and it was found that Gpx1, Gpx3,
Gpx4, Sepp1, Trxr1 expression in blood were comparable
with those observed in the major organs (Evenson et al.
2004).
Regulation of selenoprotein mRNA under Se dietary
deﬁciency presents diversity, from dramatic decrease in
Gpx1 mRNA to lack of changes for Gpx4 mRNA. Low
selenoprotein mRNA observed in rodents reﬂect depletion
of Se supply in the diet, and adequate Se supply regulates
expression level very efﬁciently. It has been found that at
least half of the dietary Se necessary to provide plateau for
enzymatic activity or protein expression is adequate to
provide plateau for mRNA expression in liver, muscle, and
kidney of rats (Barnes et al. 2009). With increasing Se
level, selenoprotein mRNA level is expressed as hyperbolic
curve presenting plateau breakpoints at low Se supply for
majority of selenoproteins. Minimal Se requirement for
growing rats was 0.1 lg Se/g diet based on liver Se, liver,
and RBC GPx1 activity. Slightly lower dietary Se
requirements based on plasma GPx3 activity, liver TrxR
activity, and liver and kidney GPx3 activity were observed.
Based on dose–response curves for selenoprotein mRNA
indifferent tissues, the minimum dietary requirements were
lower than for physiological Se biomarkers, ranging
between 0.04 and 0.06 lg Se/g diet in liver and kidney and
was between 0.03 and 0.05 lg Se/g diet in muscles.
Besides, it has been assumed that it is not feasible to use
selenoprotein mRNA in rat tissues as a biomarker for
super-nutritional Se level (up to 0.8 lg Se/g diet). These
experiments evidently suggest that marginal level of Se in
diet is able to increase selenoprotein mRNA to adequate
level in rats and mice, what may suggest common mech-
anism in regulation of selenoprotein mRNA expression by
dietary Se supply (Barnes et al. 2009). Recently, Sunde
(2010) proposed the panel of molecular biomarkers, which
could be useful for the assessment of selenium status in rats
and might be effective as the traditional biomarker panel in
rat tissues. Gpx1, Gpx3, Selt, and Selw mRNA panel of
transcripts level was signiﬁcantly correlated with liver Se
concentration, Gpx1 and Selk mRNA were associated with
liver Gpx1 activity, while Sepw and Selk mRNA reﬂected
kidney selenium status, and Gpx1, Sepw, Txnrd1 transcripts
level correlated with Gpx1 kidney activity.
Interestingly, recent studies suggest that regulation of
selenoprotein mRNA by Se dietary status is not a general
phenomenon in rodents. It was found that in mice, majority
of analyzed selenoprotein transcripts in liver and kidney
were not signiﬁcantly regulated by Se deﬁciency (Sunde
et al. 2009). It has been found that minimum Se
requirement of the turkey is higher than for rodents (Sunde
and Hadley 2010). Dietary requirement was decreased at
least 50% in old rats as compared to requirements of young
animals (Sunde and Thompson 2009). Expression of the
majority of selenoprotein mRNA in testis, except for Gpx1,
Sepp1, Sepw, and also Apoer2, was not regulated by dietary
Se status (Schriever et al. 2009). The mRNA abundances of
the 12 selenoprotein genes in thyroid and pituitary of
young pigs were resistant to increasing Se dietary supply in
diet and also Se deﬁciency, but not in liver, where NMD
under Se deﬁciency was observed for Gpx1, Sepw, Sepn,
Txrd1. The testicular mRNA of Txnrd1 and Sep15 were
decreased by increasing dietary Se supply, indicating that
high Se status may be associated with a decrease in sele-
noprotein mRNA transcripts level (Zhou et al. 2009).
Differences in dietary minimal Se supply required for
maximal mRNA expression and/or selenoenzyme activity
suggest differential regulation depending on the type of
selenoprotein as well as tissue. Therefore, ﬁndings
regarding ranking of different selenoproteins synthesis
within tissue and also different distribution of selenopro-
teins in various tissues should be considered in establishing
a universal Se status biomarker (Sunde 2010).
Selenoprotein transcripts in humans
In 2003, the panel of experts in UK Food Standards
Agency has issued speciﬁc research recommendations after
evaluation of current knowledge regarding the assessment
of Se status, including further development of functional
biomarkers (Elsom et al. 2006). Recently, a special
emphasis is laid on the application of population of cir-
culating white blood cells (WBC) transcriptome patterns in
nutritional studies. Transcriptomics studies suggest that
genes with various functional annotations can be signiﬁ-
cantly expressed in WBC (Visvikis-Siest et al. 2007). Gene
expression patterns may be also useful to deﬁne biological
processes associated with human health and disease.
However, only a few studies assessing selenoprotein gene
expression in various populations of circulating WBC in
humans have been conducted so far (Table 2).
Human studies have not conﬁrmed the hypothesis that
selenoprotein transcript level in circulating leukocytes and
in whole blood may be the reliable biomarker of Se status
in population with adequate (Sunde et al. 2008) and sub-
optimal (Reszka et al. 2009) baseline Se level in plasma
(Fig. 1). After short-term 100 lg sodium selenite supple-
mentation, healthy subjects from the SELGEN population
were chosen at random for microarray analysis of RNA
isolated from lymphocytes. The greatest changes after Se
supplementation were observed for genes that encode
proteins functioning in protein biosynthesis. Up-regulation
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123of selenoprotein K (SelK) and selenoprotein 15 kDa
(Sep15) after Se supplementation was observed, indicating
that only a small number of selenoprotein encoding genes
was altered by different Se dietary supply (Pagmantidis
et al. 2008). Results obtained by Ravn-Haren et al. (2008a,
b) also indicated lack of Se impact on selenoprotein mRNA
expression in WBC after short- and long-term Se supple-
mentation. After 1 week of supplementation with nonor-
ganic Se or organic form among healthy young Danish
men, there were no differences in mRNA expression of
GPx1, TrR1, and SeP1 in leukocytes (Ravn-Haren et al.
2008a). Similarly, after 5 years of Se-enriched yeast sup-
plementation of the PRECISE Danish subjects, there were
no differences in the expression of GPx1 in circulating
WBC (Ravn-Haren et al. 2008b). Moreover, selenoprotein
expression level in whole blood was not signiﬁcantly
associated with Se status measured in the blood and Se
supply measured according to dietary questionnaire in UK
population (Sunde et al. 2008). The baseline Se level in UK
and Danish populations was relatively high as compared to
other European populations and it approximately averaged
100 ng/ml in plasma (Table 2). Lack of changes in sele-
noprotein mRNA levels after Se supplementation indicates
that protein synthesis may already be saturated in leuko-
cytes at such sufﬁcient Se concentration. In the small group
of 47 healthy Polish individuals, plasma Se levels were
below the level required to optimize plasma GPx3 activity
(54.3 ± 14.6 ng/ml). However, no relationship between
serum Se and GPx1, GPx3, SePP1, and Sep15 mRNA
transcripts level, as well as GPx1 and GPx3 activities and
selenoprotein mRNA expression was found (Reszka et al.
2009). Daily Se intake in studied European groups was
lower than RDI (55 lg/day) for adults in Europe and US.
The observed hyperbolic curve describing the relationship
between selenoprotein mRNA expression and dietary
supply in rodents suggests that suboptimal Se status in
humans may be sufﬁcient for selenome transcription
machinery. Interestingly, GPx1, GPx3, SePP1, and Sep15
selenoprotein mRNA expression in circulating blood leu-
kocytes was signiﬁcantly positively correlated, indicating
similar regulation of expression in circulating blood leu-
kocytes. Although signiﬁcant correlations were found
between several selenoprotein mRNAs in the circulating
blood leukocytes of healthy individuals, no correlation was
found in the blood of bladder cancer patients, which may
suggest an alteration of selenoprotein synthesis during
carcinogenesis (Reszka et al. 2009).
Modiﬁers of selenium status
Functional signiﬁcance of blood Se status is mainly related
to selenoprotein activity in speciﬁc tissues. Therefore, both
traditional and molecular biomarkers of Se status measured
in different human tissues, except for controlled Se intake,
may depend on additional major modiﬁers, like health
Table 2 Human studies on selenoprotein molecular biomarkers
Study Baseline daily
Se intake (lg)
Mean ± SD
Baseline plasma
Se level (ng/ml)
Mean ± SD
Selenoprotein gene expression
in WBC
UK, SELGEN study, n = 39, both
sexes, 6 week. Se intervention
(Pagmantidis et al. 2008)
Not presented 93.9 ± 1.7 Lymphocyte
Up-regulation:
SPS1—1.15 (1.06–1.23)
SelK—1.11 (1.04–1.19)
Sep15—1.11 (1.02–1.20)
Denmark, n = 20, 18–40 years.
old men, 1 week Se intervention
(Ravn-Haren et al. 2008a)
49.8 ± 13.6 113.2 ± 12.2 Leukocyte
No effect: GPx1, TrxR1 SePP1
Denmark, PRECISE pilot study,
n = 105, both sexes, up to
5 years. Se intervention
(Ravn-Haren et al. 2008b)
49.8 ± 13.6 93 ± 11.2 Leukocyte
No effect: GPx1
UK, n = 39, both sexes, 28 week.
Se intervention (Sunde et al. 2008)
48 ± 14 89.2 ± 12.5 Whole blood
No effect and no association between
Se status and GPx1, GPx3,
GPx4, SePP1, SepW, SepH
Poland, n = 47 healthy men
(Reszka et al. 2009)
24.2 ± 17.4 (unpublished data) 54.3 ± 14.6 Leukocyte
No association between Se
status and GPx1, GPx3,
SePP1, Sep15
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123status (e.g., endocrine and immunological status), inter-
individual variations (age, sex, genetic polymorphism),
environmental exposure, diet, medication, etc. (Fig. 2).
Therefore, establishing the Se status and intake which
would be optimal for human health seems to be very dif-
ﬁcult, especially in many populations experiencing sub-
optimal Se supply, including Europe. Epidemiological and
animal studies clearly indicate that biological effects of Se
are sex-speciﬁc, which may be associated with endocrine
regulation and also immunological status. It has been
suggested that cancer risk in men is more profoundly
inﬂuenced by Se status than in women (Waters et al. 2004).
Selenoprotein gene expression displays sexual dimorphism
in various organs of females and males, e.g., Se status was
linked to male fertility due to GPx4 function during sper-
matogenesis (Schomburg and Schweizer 2009). Sex-spe-
ciﬁc selenoprotein expression pattern may vary or be
sustained with age. In the SELGEN study, an effect of Se
supplementation was associated with GPx4 genetic poly-
morphism in a sex-speciﬁc manner (Meplan et al. 2008).
Plasma Se level is not likely to accurately reﬂect tissue Se
status or selenoenzyme activity and level. There are several
confounders potentially inﬂuencing Se level. Liver and
kidney diseases can cause alterations of SePP1 (Li et al.
2007) and GPx3 levels (Zachara et al. 2006). Se metabo-
lism may be altered in different health pathologies, e.g., in
patients with inﬂammatory diseases. During critical illness,
like sepsis, acute phase response, and other immunological
disturbances, serum Se status may be lower and insufﬁcient
to support organ function. In systemic inﬂammatory
response syndrome patients, serum Se concentration was
signiﬁcantly lower (Vincent and Forceville 2008). Tobacco
smoking or occupational exposure can also increase dietary
requirement of Se. It is generally agreed that smoking can
decrease the activity of antioxidative selenoproteins,
probably due to formation of complexes of Se with cad-
mium (Ellingsen et al. 2009).
In human population, there is a large individual varia-
tion in response to Se supplementation, appearing to be
unrelated with the baseline Se status (Brown et al. 2000),
which may clearly indicate occurrence of selenoprotein
gene variants. Recent human studies indicate that selenium
status, measured as body Se, as well as SePP1 plasma level
and GPx activity, may be signiﬁcantly inﬂuenced by
genetic polymorphism of speciﬁc selenoproteins, including
GPx1 (rs1050450) (Jablonska et al. 2009), SePP1 (rs7579,
rs3877899) (Meplan et al. 2007, 2009), GPx4 (rs713041)
(Meplan et al. 2008). The impact of SePP1 variations in
codon 234, associated with Ala to Thr change (rs3877899)
and G to A transition within 3’ untranslated region (UTR)
of SePP1 mRNA (rs7579), resulted in the alteration of Se
status before as well as after Se supplementation (Meplan
et al. 2007). These polymorphisms also inﬂuence propor-
tion of two SePP1 50 and 60 kDa isoforms in plasma,
which was proposed as the modulation factor of Se
incorporation during selenoprotein synthesis (Meplan et al.
2009). Se availability modulated by SePP1 variants,
resulting in difference in isoform pattern was restricted just
to males. Interestingly, a possible impact of gender was
observed for functional signiﬁcance of GPx4 genetic
polymorphism. Single nucleotide polymorphism in 30-UTR
of GPx4 mRNA, associated with C to T change (rs713041)
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123inﬂuenced the level of GPx4 in lymphocytes, and also other
selenoproteins; however, this effect was more evident in
females (Meplan et al. 2008). One may hypothesize that
separate molecular mechanisms for GPx4 synthesis in
testes and high dietary Se requirements in males override
genetic polymorphism in GPx4 and SePP1. Recent ﬁndings
suggest also that the association between GPx1 activity and
Se concentration, analyzed separately for each GPx1
Pro198Leu (rs1050450) genotype group, was the highest
for Pro/Pro and the lowest for Leu/Leu genotype, sug-
gesting different response of GPx1 activity to Se. This also
points to the importance of the genetic background in the
assessment of the Se status with the use of selenoprotein
biomarkers such as GPx1 activity (Jablonska et al. 2009).
Adaptation of humans to suboptimal dietary Se supply
with low Se level was observed by Finley et al. (1999)i n
healthy study participants living in New Zealand, where
people consume less Se than suggested by the RDI of
55 lg/day. Se level in blood of individuals living in low Se
areas and with low Se intake may be insufﬁcient for
maximal activity of GPx3 and level of SePP1 in plasma.
However, supplementation had no effect on Se status in
platelets and erythrocytes, which can be regarded as
indicative of long-term Se intake. Interestingly, high
retention of stable
74Se isotope in placebo individuals was
observed as compared to individuals supplemented with
30 lg Se daily for 5 months, suggesting maintenance of
critical Se pool in the human body and adaptation to low Se
status by adjusting of its secretion. Therefore, physiologi-
cal requirements of Se are lower than recommended in
humans, but enabling selenoprotein synthesis. Besides, in
patients with diseases like KBD and cancer, where low Se
level in blood is observed, down-regulation of speciﬁc
selenoprotein gene expression was found to occur in cir-
culating WBC. Signiﬁcant down-regulation of SePP1
mRNA level was observed in Han Chinese with KBD (Sun
et al. 2010). In Caucasian bladder cancer male patients,
SePP1, GPx1, GPx3, Sep15 mRNA levels were lower than
in the control group (Reszka et al. 2009). Preferential
incorporation of Sec into selenoprotein mRNA in circu-
lating blood leukocytes under relatively low Se supply
merits investigations intended to identify potential sensi-
tive and resistant selenoproteins under Se deﬁciency in
humans.
Concluding remarks
While the levels of Se required for optimization of SePP1
and GPx3 activities in plasma are well known, estimating
Se level that is required for maximal selenoprotein gene
expression in humans requires further research. According
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123to rodents studies and studies among humans, which have
been discussed in this review, it appears that suboptimal Se
intake may be sufﬁcient to achieve selenoprotein mRNA
expression and molecular requirements of Se are lower
than the established recommended dietary intake in
humans—55 lg/day (EFSA 2008; NAS 2000). It should be
noted that the expression of individual selenoprotein
mRNA may be not always linked with protein expression.
Therefore, since we have not understood the transcriptional
and translational link of selenoprotein under different Se
supply in different human tissues, biological functionality
of selenoprotein could be recognized only at protein level.
Preferential incorporation of Se into selenoproteins in
rodents was observed even at suboptimal dietary Se level.
In rats, minimum Se requirements for achieving a plateau
of selenoprotein mRNA expression have been low, reached
plateau at half of the dietary Se concentration required for
maximal activity of GPx1, GPx3, and maximal level of
SePP1 in different tissues (Barnes et al. 2009). Therefore,
in rodents, selenoprotein mRNA expression does not seem
to be a good indicator for Se status. Hypothetically, in
almost all populations, even in those with low and mod-
erate Se intake and Se level in blood compartments, sele-
noprotein encoding gene expression might reach the
plateau levels and serve as a sensitive functional biomarker
of Se status. However, it should be noted that regulation of
selenoprotein gene expression, metabolic pathways, and
responses to Se interventions in animals may differ from
those in humans. None of the human studies conducted so
far has indicated that selenoprotein mRNA in the whole
blood and blood cells may be a good indicator of Se status
in humans (Pagmantidis et al. 2008; Ravn-Haren et al.
2008a, b; Reszka et al. 2009; Sunde et al. 2008). Low Se
status may be adequate for proper regulation of seleno-
protein transcription, but not for proper physiological
activity of selenoproteins. Preferential incorporation of Se
into selenoprotein and its optimal saturation at low dietary
Se level does not provide adequate activities and seleno-
protein expression in different tissues. Therefore, it may be
suggested that functional rather than molecular biomarkers
of Se are optimal indicators of its supply. It seems rea-
sonable to conclude that SePP1 concentration in plasma
may clearly indicate sub-optimal to optimal Se supply,
because it can reﬂects functional signiﬁcance of Se activity
in organism. In over-optimal Se supply, where SePP1 level
is optimized, plasma Se seems to reﬂect Se intake and
achieved Se status.
All possible modiﬁers of Se status determined by means
of biochemical and molecular techniques, including smok-
ing,occupationalexposure,diet,healthparameters,sex,age,
endocrine and immunological status, should be included, as
these factors can potentially modulate selenoprotein gene
expression. Impact of polymorphism of selenoproteins
should be also included in complete analysis of Se require-
ments of individuals with different genotypes and haplo-
types. Therefore, comprehensive intervention studies of
circulating leukocyte selenoprotein transcript levels in a
population with suboptimal and with adequate compared to
over-optimal selenium status should be conducted.
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